James Beardsley

Infectious Diseases Clinical Specialist; Assistant Professor of Medicine

Wake Forest Baptist Medical Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Microbiology Microbiology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

James Beardsley is an Assistant Professor of Medicine at Wake Forest Baptist Health in the United States. His research primarily focuses on infectious diseases, with recent articles examining topics such as extended-spectrum beta-lactamase-producing bacteria, multiplex rapid diagnostic panels, and antibiotic stewardship. He also investigates the clinical and economic impacts of antibiotic therapies and interventions in inpatient settings.

Articles (8)

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (1)

Vera Luther

Professor of Medicine

Wake Forest School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

James Beardsley

Research Interests

Explore related searches

Contact this professor

About

Articles (8)

Analysis of infections among patients with historical culture positive for extended-spectrum beta-lactamase (ESBL)–producing Escherichia coli or Klebsiella pneumoniae: Is ESBL-targeted therapy always needed?

Clinical impact of a multiplex rapid diagnostic pneumonia panel in critically ill patients

Evaluating the Use of Dalbavancin for Off-Label Indications

Inpatient Antibiotic Costs Associated With Switching From Vancomycin to Daptomycin for Outpatient Parenteral Antibiotic Therapy

A comparison of active versus passive methods of responding to rapid diagnostic blood culture results

Impact of an Interprofessional Collaborative Quality Improvement Initiative to Decrease Inappropriate Thyroid Function Testing

Multicenter point prevalence evaluation of the utilization and safety of drug therapies for COVID-19 at the onset of the pandemic timeline in the United States

Impact of order entry alerts and modifications on doses of intravenous opioids dispensed during a national drug shortage

Collaborators (1)

Vera Luther

Make your next move.